Evidence map›Paper›PMID 36813261›Full record

ArticleBiochemistry2023

DJ-1 Molecular Chaperone Activity Depresses Tau Aggregation Propensity through Interaction with Monomers.

Daniela Jimenez-Harrison, Carol J Huseby, Claire N Hoffman, Steven Sher, Dalton Snyder, Brayden Seal, Chunhua Yuan, Hongjun Fu, Vicki Wysocki, Flaviano Giorgini and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Daniela Jimenez-HarrisonMedical Scientist Training Program, The Ohio State University, Columbus, Ohio 43210, United States.ORCID 0000-0003-0786-7988
Carol J HusebyDepartment of Biological Chemistry and Pharmacology, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.
Claire N HoffmanDepartment of Biological Chemistry and Pharmacology, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.
Steven SherMedical Scientist Training Program, The Ohio State University, Columbus, Ohio 43210, United States.
Dalton SnyderDepartment of Chemistry and Biochemistry, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.
Brayden SealDepartment of Biological Chemistry and Pharmacology, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.
Chunhua YuanCampus Chemical Instrument Center, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.
Hongjun FuDepartment of Neuroscience, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.
Vicki WysockiDepartment of Chemistry and Biochemistry, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.
Flaviano GiorginiDepartment of Genetics and Genome Biology, University of Leicester, Leicester LE1 7RH, United Kingdom.
Jeff KuretDepartment of Biological Chemistry and Pharmacology, The Ohio State University College of Medicine, Columbus, Ohio 43210, United States.ORCID 0000-0002-8083-8406
The Ohio State University · USUniversity of Leicester · GB

Funding

Waters Select Series Cyclic IMS for P41 Native MS Resource Application to Alzheimer's DiseaseP41GM128577 · NIGMS · OHIO STATE UNIVERSITY · PI WYSOCKI, VICKI H. · 2018 to 2022
$7.6M
Structure and Genesis of tau AggregatesRF1AG054018 · NIA · OHIO STATE UNIVERSITY · PI KURET, JEFF · 2017 to 2022
$4.4M
Molecular Biophysics predoctoral training at The Ohio State UniversityT32GM118291 · NIGMS · OHIO STATE UNIVERSITY · PI BUNDSCHUH, RALF A, KURET, JEFF · 2017 to 2021
$720k
NIA NIH HHS RF1 AG054018NIGMS NIH HHS P41 GM128577NIGMS NIH HHS T32 GM118291
6 · The paper itself

Abstract

Tau aggregate-bearing lesions are pathological markers and potential mediators of tauopathic neurodegenerative diseases, including Alzheimer's disease. The molecular chaperone DJ-1 colocalizes with tau pathology in these disorders, but it has been unclear what functional link exists between them. In this study, we examined the consequences of tau/DJ-1 interaction as isolated proteins

Indexed as

Neurodegenerative DiseasesParkinson Diseasealpha-SynucleinHumansMolecular ChaperonesProtein Deglycase DJ-1tau Proteinsalpha-SynucleinMolecular ChaperonesProtein Deglycase DJ-1tau Proteins

Identifiers

PMID36813261
PMCPMC9997487
OpenAlexW4321480125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.